Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M de Haan

Showing results (261-270 of 303) with videos related to

Pageof 31
Sort By:
Bladder Cancer (Amsterdam, Netherlands)|August 9, 2016
Elevated Derived Neutrophil-to-Lymphocyte Ratio Corresponds With Poor Outcome in Patients Undergoing Pre-Operative Chemotherapy in Muscle-Invasive Bladder CancerKim E M van Kessel, Lorraine M de Haan, Elisabeth E Fransen van de Putte, et al.
Endocrine|April 26, 2020
The role of AIP variants in pituitary adenomas and concomitant thyroid carcinomas in the Netherlands: a nationwide pathology registry (PALGA) studyE C Coopmans, A Muhammad, A F Daly, et al.
Clinical and Experimental Immunology|August 22, 2023
Difference in respiratory syncytial virus-specific Fc-mediated antibody effector functions between children and adultsAnke J Lakerveld, Anne T Gelderloos, Rutger M Schepp, et al.
Journal of Virology|February 17, 2017
Mutation of the Second Sialic Acid-Binding Site, Resulting in Reduced Neuraminidase Activity, Preceded the Emergence of H7N9 Influenza A VirusMeiling Dai, Ryan McBride, Jos C F M Dortmans, et al.
Cell Research|September 5, 2012
Coxsackievirus mutants that can bypass host factor PI4KIIIβ and the need for high levels of PI4P lipids for replicationHilde M van der Schaar, Lonneke van der Linden, Kjerstin H W Lanke, et al.
Antiviral Research|June 15, 2007
Antiviral activity of carbohydrate-binding agents against Nidovirales in cell cultureF J U M van der Meer, C A M de Haan, N M P Schuurman, et al.
Journal of Nanobiotechnology|March 10, 2025
A bivalent spike-targeting nanobody with anti-sarbecovirus activityIris C Swart, Oliver J Debski-Antoniak, Aneta Zegar, et al.
NPJ Vaccines|May 31, 2024
Nanoparticle display of neuraminidase elicits enhanced antibody responses and protection against influenza A virus challengeM N Pascha, M Ballegeer, M C Roelofs, et al.
Journal of Virology|August 6, 2010
Recombinant soluble, multimeric HA and NA exhibit distinctive types of protection against pandemic swine-origin 2009 A(H1N1) influenza virus infection in ferretsBerend Jan Bosch, Rogier Bodewes, Robert P de Vries, et al.
Plos Pathogens|June 11, 2019
The 2nd sialic acid-binding site of influenza A virus neuraminidase is an important determinant of the hemagglutinin-neuraminidase-receptor balanceWenjuan Du, Hongbo Guo, Vera S Nijman, et al.
Pageof 31

Showing results (261-270 of 303) with videos related to

Sort By:
Pageof 31
Bladder Cancer (Amsterdam, Netherlands)|August 9, 2016
Elevated Derived Neutrophil-to-Lymphocyte Ratio Corresponds With Poor Outcome in Patients Undergoing Pre-Operative Chemotherapy in Muscle-Invasive Bladder CancerKim E M van Kessel, Lorraine M de Haan, Elisabeth E Fransen van de Putte, et al.
Endocrine|April 26, 2020
The role of AIP variants in pituitary adenomas and concomitant thyroid carcinomas in the Netherlands: a nationwide pathology registry (PALGA) studyE C Coopmans, A Muhammad, A F Daly, et al.
Clinical and Experimental Immunology|August 22, 2023
Difference in respiratory syncytial virus-specific Fc-mediated antibody effector functions between children and adultsAnke J Lakerveld, Anne T Gelderloos, Rutger M Schepp, et al.
Journal of Virology|February 17, 2017
Mutation of the Second Sialic Acid-Binding Site, Resulting in Reduced Neuraminidase Activity, Preceded the Emergence of H7N9 Influenza A VirusMeiling Dai, Ryan McBride, Jos C F M Dortmans, et al.
Cell Research|September 5, 2012
Coxsackievirus mutants that can bypass host factor PI4KIIIβ and the need for high levels of PI4P lipids for replicationHilde M van der Schaar, Lonneke van der Linden, Kjerstin H W Lanke, et al.
Antiviral Research|June 15, 2007
Antiviral activity of carbohydrate-binding agents against Nidovirales in cell cultureF J U M van der Meer, C A M de Haan, N M P Schuurman, et al.
Journal of Nanobiotechnology|March 10, 2025
A bivalent spike-targeting nanobody with anti-sarbecovirus activityIris C Swart, Oliver J Debski-Antoniak, Aneta Zegar, et al.
NPJ Vaccines|May 31, 2024
Nanoparticle display of neuraminidase elicits enhanced antibody responses and protection against influenza A virus challengeM N Pascha, M Ballegeer, M C Roelofs, et al.
Journal of Virology|August 6, 2010
Recombinant soluble, multimeric HA and NA exhibit distinctive types of protection against pandemic swine-origin 2009 A(H1N1) influenza virus infection in ferretsBerend Jan Bosch, Rogier Bodewes, Robert P de Vries, et al.
Plos Pathogens|June 11, 2019
The 2nd sialic acid-binding site of influenza A virus neuraminidase is an important determinant of the hemagglutinin-neuraminidase-receptor balanceWenjuan Du, Hongbo Guo, Vera S Nijman, et al.
Pageof 31